Generic medicine

Metformin + Rosiglitazone

Follow price changes

Metformin + Rosiglitazone · ATC A10BD · Endocrine & metabolic · Antidiabetic medicines

Data statusRegistration & price fields require source verification.

1brand families

2registered presentations

1companies

2with current prices

Available dosage forms

Choose a form

Tap a form to filter the brand list

Tablet2 products

Advertisement · clearly labelled sponsored placement

Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.

Print / Save PDFAll 2 presentations 1 brands · 2 presentations

Brand	Manufacturer	Registered presentations
Rozicon-M2 presentations	Amarant Pharmaceuticals Private Limited	500 mg + 2 mg Tablet 14's 055976 PKR 318.052026-07-23 PKR 22.72/ tablet 500 mg + 4 mg Tablet 14's 057789 PKR 506.002026-07-23 PKR 36.14/ tablet

Price movement

Official price changes for Metformin + Rosiglitazone

No change in the official DRAP price is recorded yet for any of the 2 tracked presentations (records from 23 Jul 2026).

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC A10BD

MedInfoBase. (2026). Metformin + Rosiglitazone — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 27, 2026, from https://medinfobase.com/generic/metformin-rosiglitazone/ ATC A10BD.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.